MHealth Market - Global Mobile Health Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

According to a new market report published by Transparency Market Research "mHealth Market- Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global mHealth market is expected to reach USD 10.2 billion by 2018 from USD 1.3 billion in 2012 at a CAGR of 41.5% from 2012 to 2018. The monitoring services segment is in commanding position having contributed about 63% of the global mHealth market revenue in 2012.

Browse the full report at  http://www.transparencymarketresearch.com/mobile-health-market.html 

The global mHealth market is primarily driven by factors such as the increasing adoption of smartphones and rising incidences of chronic diseases. The development in smartphone applications has created new and interactive ways of communication between patients and healthcare providers. Use of smartphone applications is expected to revolutionize the mHealth market by improving healthcare delivery and dissemination of medical information.

The most impactful trend witnessed in the mHealth market is the growth in remote patient monitoring. Remote monitoring of patients can help reduce costs significantly by reducing the amount of time the patient spends in hospitals and also by lowering the frequency of follow-up visits to the physician. In addition, quick service and ease of use functionalities, and rising healthcare expenditure are supporting faster adoption of mHealth applications. Moreover, increasing demand for independent aging solutions and post-acute care services are also aiding the mHealth market growth.

The report analyzes the global mHealth market with cross sectional analysis of its various services and the players involved in the ecosystem. Based on the services, the market is segmented into - monitoring services, diagnostic services, healthcare system strengthening services and other services. The mHealth market ecosystem is analyzed in respect with major value system participants such as mobile operators, device vendors, content players and healthcare providers.

The monitoring services segment holds the largest share of about 63% of the global mHealth market followed by diagnostic services and healthcare systems strengthening. The monitoring services segment will also be the fastest growing during the forecast period, owing to their usability in acute conditions such as coronary artery disease, hypertension, and congestive heart failure. The contribution of monitoring services to the overall mHealth revenues will be greater in countries with higher income levels.

Within the mHealth participants' landscape, mobile operators hold majority of the market share of 50% followed by device vendors, content developers and healthcare providers. Mobile operators are gaining majority of the mHealth revenues from monitoring services, whereas diagnosis and treatment solutions will also be attractive opportunities for operators in the near future.

North America commands the largest share of mHealth market revenue followed by Europe and the Asia Pacific region. The current mHealth deployments in the Asia Pacific region are primarily focused on improving the efficiency of the healthcare workforce and systems. India is emerging as one of the mHealth hotspots in the region with a varied range of mHealth solution launches. Though the mHealth market has witnessed increasing influence of emerging economies, highest per capita expenditure on mHealth applications will continue to be from developed regions such as the U.S. and Canada, owing to an increasing percentage of chronic diseases and higher disposable income.

The mHealth market consists of a mix of players from different categories namely mobile operators, content developers, device vendors and healthcare providers. AT&T, AllScripts Healthcare Solutions, AirStrip Technologies, Qualcomm, Vodafone, Soft Serve, HealthSaaS and mQure are a few active key players across different categories mentioned above.

Browse the full report at  http://www.transparencymarketresearch.com/mobile-health-market.html 

Read More

Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research, the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.

The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.

The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are - molecular medicine, gene therapy, drug development and preventive medicine.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Read More

General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018

According to the latest market report published by Transparency Market Research "General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018", the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report at http://www.transparencymarketresearch.com/general-medicine-education-publishing.html 

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

General Medicine or internal medicine is a branch of medicine which deals with the prevention, diagnosis and subsequent treatment of adult diseases. The specialists who deal with this branch of medicine are called “internists” and ones who work with children are called pediatricians. General Medicine is further specialized depending on the organ or organ systems, such as cardiology, anesthesiology, endocrinology, nephrology etc. On an average 75,000 medical students choose internal medicine as a career option annually around the world. 

The global publishing market for general medicine education is highly dynamic in nature since there is a strong disparity in the availability and adoption of modern technology along with its cost. It is estimated that in the Asian and developing European regions along with RoW, more than half of the people do not have access to internet as a source of education in their homes. This severely undermines the quality of education. Printed books and literature are thus the major tools of spreading education here.

The report presents an excellent environmental analysis with emphasis on market drivers, restraints and future opportunities. It gives an impact of various factors on the market with a business perspective and highlights potential shortcomings, advantages for key players and new entrants as well. The global publishing market for general medicine education is highly dynamic in nature since there is a strong disparity in the availability and adoption of modern technology along with its cost. It is estimated that in the Asian and poorer European regions along with RoW, more than half of the people do not have access to internet as a source of education in their homes. This severely undermines the quality of education. Printed books and literature are thus the major tools of spreading education here.

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson's Principles and Practice of medicine.

A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:

Electronic & online publishing market for general medicine education

• Online Reference Tools
• Mobile Applications
• Electronic & Digital textbooks and reference books
• Multimedia Content
• Testing & Self-Assessmen
• Hospital Training
• Distance Learning

Print publishing market for general medicine education

• Custom content publishing
• Print textbooks and reference books
• Testing & Self-Assessment
• Hospital Training
• Distance Learning

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

North America

Europe

Asia

Rest of the World (RoW)

Browse the full report at http://www.transparencymarketresearch.com/general-medicine-education-publishing.html 

Read More

Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research , the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The “Bioinformatics Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 – 2018” report includes study of the global market for bioinformatics across different sub segments and geographies. The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are – molecular medicine, gene therapy, drug development and preventive medicine.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.

The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are - molecular medicine, gene therapy, drug development and preventive medicine.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

Read More

High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Growth, Share And Forecast, 2012 - 2018

In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments. Moreover, the report provides detailed and in-depth analysis of the HPAPI market, with their estimated figures and forecast from 2012 to 2018, along with compound annual growth rate from 2012 to 2018.

The global high-potency active pharmaceutical ingredients market has shown favorable growth trend in the last few years and is expected to grow rapidly in the forecasted period. The demand of oncology products is further expected to drive the growth of this market. The high level of competition in this market is due to new entrants fragmenting the market. HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018. The drivers, restraints and opportunities have also been covered broadly in this report along with their impact analysis. These market dynamics will be highly helpful in taking corporate decisions related to the HPAPI market.

High potency active pharmaceutical ingredients (HPAPIs) are growing rapidly as compared to other segments of the healthcare industry. HPAPI are the compounds helpful in the treatment of respiratory disorders, treatment of cancer and hormonal imbalances. Growing oncology therapeutics market worldwide is the key factor driving the growth of this market.

High Potency Active Pharmaceutical Ingredients Market is a growing concept and is considered to be a boost to the pharmaceutical industry. Patented high potency drug development majorly dominates the HPAPI market. The branded sector constitutes the major share of this market but the patents of this branded sector are expected to expire in the coming few years that will help HPAPI manufacturers to cater to multiple clients by producing the generic version of the ingredients in bulk.

Some of the factors driving this market at a rapid growth rate are majority of blockbuster drugs nearing patent expiry, US government promoting generic drugs to reduce its medical burden, insurance companies preferring generic drugs over patented drugs for cost effectiveness and India and China with maximum DMFs with the US FDA.

However, a large number of competitors are entering this market making it highly fragmented which may slow down the growth of this market. Moreover, reduced R&D investments leading to low demand of HPAPIs and shortage of US FDA approved manufacturing sites are also likely to be the major restraints for the growth of the high potency active pharmaceutical ingredients market.

However, North America has been the largest market for high potency pharmaceutical ingredients as the country spends highly on the development of healthcare systems, whereas the European market has experienced several fluctuations in the past few years but is expected to grow rapidly in the near future due to rise in the demand of oncology drugs in this region.

Browse Report : http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

Read More

Seasonal Influenza Vaccines Industry In Top Seven Countries To 2018 - Next Generation Quadrivalent Vaccines To Dominate The Market By Offering Broader Protection Via Single Dose

GBI Research, the leading business intelligence provider, has released its latest research, Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose, which provides essential insights into seasonal influenza vaccines sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2018. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes insights into the seasonal influenza vaccine R&D pipeline and gives profiles of promising vaccines, as well as exploring the competitive landscape through profiles for the top companies. Key trends in terms of M&A and licensing agreements are also analyzed.

Browse Report : Seasonal Influenza Vaccines Market In Top Seven Countries To 2018

GBI Research expects the market to grow at a Compound Annual Growth Rate (CAGR) of 3.9% during the 20112018 period from $2.9 billion in 2011 to $3.8 billion by 2018, driven by growing awareness, increasing vaccination coverage and rising government support for immunization against seasonal influenza. On the other hand, limited production capacity, high investment and strict regulations may act as barriers to entry.

The US seasonal influenza vaccine market is the most attractive of those covered in the report in terms of value. It is forecast to increase from $1.6 billion in 2011 to $2.2 billion in 2018 at a CAGR of 4.8%, due to the growth of the aging population, higher disease awareness and the fact that being vaccinated has become more convenient. The UK on the other hand has the most attractive market in terms of growth rate, forecast to grow at CAGR of 6.3% between 2011 and 2018. Germanys market is also attractive and is forecast to grow at a CAGR of 2.7% between 2011 and 2018 from $385.5m to $465m. The market in Japan is forecast to grow at CAGR of 1.6% between 2011 and 2018 to reach $621.5m by 2018, driven by the threat of pandemic influenza and higher awareness of influenza vaccination. The government-run influenza immunization program is also helping to increase vaccination coverage.

GBI Researchs analysis shows that the R&D pipeline for seasonal influenza vaccines comprises a high number of vaccines in early-stage development, many of which are new formulations or those that have been developed using the cell culture method. Late-stage vaccines are either quadrivalent vaccines or pediatric versions of those that have already been approved. The market is currently dominated by trivalent vaccines but will witness the launch of quadrivalent vaccines in the near future.

Read More : Seasonal Influenza Vaccines Industry

Scope

• Data and analysis on the seasonal influenza vaccine market in the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan
• Market forecasts for seasonal influenza vaccines until 2018
• Market data on geographical landscape in terms of country, vaccination coverage, public and private contribution to the total number of doses, vaccine price and market size
• Key drivers and restraints that have had a significant impact on the market
• Regulatory landscape, including the approval process and an overview of the regulatory authorities in the top seven countries
• Competitive landscape of the seasonal influenza vaccine market in the top seven countries including top companies profiles, namely Sanofi, Johnson & Johnson, GlaxoSmithKline Biologicals, Novartis Vaccines and AstraZeneca
• Key M&A activities and licensing agreements that have taken place between 2009 and mid-2012

Reasons to buy

• Build effective strategies to launch pipeline products by identifying potential geographies
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill portfolio gaps
• Develop key strategic initiatives by studying top competitors key strategies
• Develop market-entry and market-expansion strategies by identifying the markets poised for strong growth
• Reinforce R&D pipelines by identifying new target mechanisms able to produce safer and more efficacious first-in-class vaccines

Browse : http://www.businessresearchindustry.com/report/seasonal-influenza-vaccines-market-in-top-seven-countries-to-2018-next-generation-quadrivalent-vaccines-to-dominate-the-market-by-offering-broader-protection-via-single-dose.htm

Read More

Gastrointestinal Disorders Therapeutics Industry To 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) And Ulcerative Colitis (UC) To Reinvigorate The Market

GBI Research, the leading business intelligence provider, has released its latest research, Gastrointestinal Disorders Therapeutics Market to 2018 Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market, which provides insights into the gastrointestinal disorders therapeutics market until 2018. 

Browse : Gastrointestinal Disorders Therapeutics Industry

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. It provides in-depth analysis of the major diseases, comprising IBS, constipation, Crohns disease, UC, Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD). The report also gives the size of the generic share in the global gastrointestinal disorders therapeutics market and in those of the US, the top five countries of Europe, and Japan, as well as treatment usage patterns and geographical distribution. Additionally, it includes insights into the R&D product pipeline and explores the competitive landscape, looking at major players and including analysis of M&A, licensing agreements and co-development deals that have taken place in the past two years.

GBI Researchs analysis shows that the gastrointestinal disorders therapeutics market is set to witness high generic competition in the forecast period, as major drugs used in the treatment of the aforementioned disorders are set to expire, resulting in declining revenues and allowing generics to enter the market. Nevertheless, the market will witness steady growth due to the anticipated entry of innovative new drugs in the near future. Furthermore, strong R&D in IBS, constipation, Crohns disease and UC remains a key market driver.

Scope

• Data and analysis for the gastrointestinal disorders therapeutics markets in the leading geographies: the US; the top five countries of Europe, comprising the UK, Germany, France, Italy and Spain; Japan; and an overview of India, China and Australia
• Annualized market data for the gastrointestinal disorders therapeutics market from 2004 to 2010 and forecast to 2018
• Market data for the geographical and therapeutic landscapes, including size, share, annual cost of therapy, sales volume and treatment usage patterns for the diseased population, diagnosis population and prescription population
• Generic share in the global market and for each indication
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the global market, looking at key companies such as AstraZeneca, Takeda, Johnson & Johnson , Eisai, Abbott, Shire and Salix
• Key M&A activity and licensing agreements that took place between 2010 and 2012

Read Report : Gastrointestinal Disorders Therapeutics Market To 2018 

Reasons to buy

• Align product portfolios to the markets with high growth potential
• Build effective strategies to launch pipeline products by identifying potential geographies
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill portfolio gaps
• Develop key strategic initiatives by studying top competitors key strategies
• Device a more tailored country strategy by understanding the key drivers, barriers and market potential for each indication
• Develop market-entry and market-expansion strategies by identifying the markets poised for strong growth
• Reinforce R&D pipelines by identifying new target mechanisms producing safer and more efficacious FIC molecules

Browse : http://www.businessresearchindustry.com/report/gastrointestinal-disorders-therapeutics-market-to-2018-novel-agents-targeting-irritable-bowel-syndrome-ibs-chronic-constipation-cc-and-ulcerative-colitis-uc-to-reinvigorate-the-market.htm

Read More